-
2
-
-
36048981531
-
-
F. Maggiolo M. Airoldi H. D. Kleinloog A. Callegaro V. Ravasio C. Arici E. Bombana F. Suter HIV Clin. Trials 2007 8 282
-
(2007)
HIV Clin. Trials
, vol.8
, pp. 282
-
-
Maggiolo, F.1
Airoldi, M.2
Kleinloog, H.D.3
Callegaro, A.4
Ravasio, V.5
Arici, C.6
Bombana, E.7
Suter, F.8
-
6
-
-
57349096037
-
-
Z. K. Sweeney S. F. Harris N. Arora H. Javanbakht Y. Li J. Fretland J. P. Davidson J. R. Billedeau S. K. Gleason D. Hirschfeld J. J. Kennedy-Smith T. Mirzadegan R. Roetz M. Smith S. Sperry J. Suh J. Wu S. Tsing A. G. Villasenor A. Paul G. Su G. Heilek J. Q. Hang A. S. Zhou J. A. Jernelius F.-J. Zhang K. Klumpp J. Med. Chem. 2008 51 7449
-
(2008)
J. Med. Chem.
, vol.51
, pp. 7449
-
-
Sweeney, Z.K.1
Harris, S.F.2
Arora, N.3
Javanbakht, H.4
Li, Y.5
Fretland, J.6
Davidson, J.P.7
Billedeau, J.R.8
Gleason, S.K.9
Hirschfeld, D.10
Kennedy-Smith, J.J.11
Mirzadegan, T.12
Roetz, R.13
Smith, M.14
Sperry, S.15
Suh, J.16
Wu, J.17
Tsing, S.18
Villasenor, A.G.19
Paul, A.20
Su, G.21
Heilek, G.22
Hang, J.Q.23
Zhou, A.S.24
Jernelius, J.A.25
Zhang, F.-J.26
Klumpp, K.27
more..
-
7
-
-
47749136565
-
-
Z. K. Sweeney S. Acharya A. Briggs J. P. Dunn T. R. Elworthy J. Fretland A. M. Giannetti G. Heilek Y. Li A. C. Kaiser M. Martin Y. D. Saito M. Smith J. M. Suh S. Swallow J. Wu J. Q. Hang A. S. Zhou K. Klumpp Bioorg. Med. Chem. Lett. 2008 18 4348
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4348
-
-
Sweeney, Z.K.1
Acharya, S.2
Briggs, A.3
Dunn, J.P.4
Elworthy, T.R.5
Fretland, J.6
Giannetti, A.M.7
Heilek, G.8
Li, Y.9
Kaiser, A.C.10
Martin, M.11
Saito, Y.D.12
Smith, M.13
Suh, J.M.14
Swallow, S.15
Wu, J.16
Hang, J.Q.17
Zhou, A.S.18
Klumpp, K.19
-
8
-
-
47749109429
-
-
Z. K. Sweeney J. Dunn Y. Li G. Heilek P. Dunten T. R. Elworthy X. Han S. F. Harris D. R. Hirschfeld J. H. Hogg W. Huber A. C. Kaiser D. J. Kertesz W. Kim T. Mirzadegan M. G. Roepel Y. D. Saito T. M. P. C. Silva S. Swallow J. L. Tracy A. Villasenor H. Vora A. S. Zhou K. Klumpp Bioorg. Med. Chem. Lett. 2008 18 4352
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4352
-
-
Sweeney, Z.K.1
Dunn, J.2
Li, Y.3
Heilek, G.4
Dunten, P.5
Elworthy, T.R.6
Han, X.7
Harris, S.F.8
Hirschfeld, D.R.9
Hogg, J.H.10
Huber, W.11
Kaiser, A.C.12
Kertesz, D.J.13
Kim, W.14
Mirzadegan, T.15
Roepel, M.G.16
Saito, Y.D.17
Silva, T.M.P.C.18
Swallow, S.19
Tracy, J.L.20
Villasenor, A.21
Vora, H.22
Zhou, A.S.23
Klumpp, K.24
more..
-
9
-
-
58549120191
-
-
Ab initio calculations on a model system confirmed that fluorination increased the electropositive character of the relevant aromatic hydrogen atom
-
Z. K. Sweeney J. J. Kennedy-Smith J. Wu N. Arora J. R. Billedeau J. P. Davidson J. Fretland J. Q. Hang G. M. Heilek S. Harris D. Hirschfeld P. Inbar H. Javanbakht J. A. Jernelius Q. Jin Y. Li W. Liang R. Roetz K. Sarma M. Smith D. Stefanidis G. Su J. M. Suh A. G. Villasenor M. Welch F.-J. Zhang K. Klumpp ChemMedChem 2009 4 88
-
(2009)
ChemMedChem
, vol.4
, pp. 88
-
-
Sweeney, Z.K.1
Kennedy-Smith, J.J.2
Wu, J.3
Arora, N.4
Billedeau, J.R.5
Davidson, J.P.6
Fretland, J.7
Hang, J.Q.8
Heilek, G.M.9
Harris, S.10
Hirschfeld, D.11
Inbar, P.12
Javanbakht, H.13
Jernelius, J.A.14
Jin, Q.15
Li, Y.16
Liang, W.17
Roetz, R.18
Sarma, K.19
Smith, M.20
Stefanidis, D.21
Su, G.22
Suh, J.M.23
Villasenor, A.G.24
Welch, M.25
Zhang, F.-J.26
Klumpp, K.27
more..
-
12
-
-
72249123164
-
-
J. Guillemont A. Benjahad S. Oumouch L. Decrane P. Palandjian D. Vernier L. Queguiner K. Andries M.-P. de Bethune K. Hertogs D. S. Grierson C. H. Nguyen J. Med. Chem. 2009 52 7473
-
(2009)
J. Med. Chem.
, vol.52
, pp. 7473
-
-
Guillemont, J.1
Benjahad, A.2
Oumouch, S.3
Decrane, L.4
Palandjian, P.5
Vernier, D.6
Queguiner, L.7
Andries, K.8
De Bethune, M.-P.9
Hertogs, K.10
Grierson, D.S.11
Nguyen, C.H.12
-
13
-
-
28144445329
-
-
D. Himmel K. Das A. D. Clark S. H. Hughes A. Benjahad S. Oumouch J. Guillemont S. Coupa A. Poncelet I. Csoka C. Meyer K. Andries C. H. Nguyen D. S. Grierson E. Arnold J. Med. Chem. 2005 48 7582
-
(2005)
J. Med. Chem.
, vol.48
, pp. 7582
-
-
Himmel, D.1
Das, K.2
Clark, A.D.3
Hughes, S.H.4
Benjahad, A.5
Oumouch, S.6
Guillemont, J.7
Coupa, S.8
Poncelet, A.9
Csoka, I.10
Meyer, C.11
Andries, K.12
Nguyen, C.H.13
Grierson, D.S.14
Arnold, E.15
-
14
-
-
79952504265
-
-
A very recent patent application from Merck published after our work was complete also describes 4-aryloxypyridones: WO2009067166
-
A very recent patent application from Merck published after our work was complete also describes 4-aryloxypyridones: T. J. Tucker, R. Tynebor, J. T. Sisko, N. Anthony, R. Gomez and S. M. Jolly, WO2009067166
-
-
-
Tucker, T.J.1
Tynebor, R.2
Sisko, J.T.3
Anthony, N.4
Gomez, R.5
Jolly, S.M.6
-
15
-
-
79952496485
-
-
For a detailed description of the in vitro assays see: WO2008119662 Protein purification and crystallization was performed as described in ref. 6a. Crystallographic data for the cocrystal structure of 2b and HIVRT has been deposited in the PDB
-
For a detailed description of the in vitro assays see: Z. K. Sweeney and M. Welch, WO2008119662
-
-
-
Sweeney, Z.K.1
Welch, M.2
-
16
-
-
0003845223
-
-
Graphics were prepared using Pymol. See: DeLano Scientific, Palo Alto, CA, For the model of 4c in the NNRTI binding pocket see the ESI.
-
Graphics were prepared using Pymol. See: W. L. DeLano, The PyMOL Molecular Graphics System, 2002, DeLano Scientific, Palo Alto, CA, www.pymol.org
-
(2002)
The PyMOL Molecular Graphics System
-
-
Delano, W.L.1
-
17
-
-
0034640387
-
-
-1 in a medium-throughput thermodynamic solubility assay The open NNRTI binding pocket of diaryl ether pyridazinone inhibitors (ref. 6c) was selected for modeling inhibitors presented in this paper. An essential water molecule (captured in the pyridazinone structure) is required to dock the pyridone correctly so that the pyridone CO makes a water-mediated hydrogen bond with K101 backbone NH, while the NH group of the pyridone makes a hydrogen bond with the backbone carbonyl of K101
-
J. Ren C. Nichols L. E. Bird T. Fujiwara H. Sugimoto D. I. Stuart D. K. Stammers J. Biol. Chem. 2000 275 14316
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 14316
-
-
Ren, J.1
Nichols, C.2
Bird, L.E.3
Fujiwara, T.4
Sugimoto, H.5
Stuart, D.I.6
Stammers, D.K.7
-
18
-
-
79952496703
-
-
Lead optimization was guided using models prepared using the molecular mechanics program MOLOC. Ligand molecules were optimized in the protein environment using the MAB forcefield and 500 steps of conjugate gradient optimization. No constraints were placed on the ligand atoms during minimization. See:
-
Lead optimization was guided using models prepared using the molecular mechanics program MOLOC. Ligand molecules were optimized in the protein environment using the MAB forcefield and 500 steps of conjugate gradient optimization. No constraints were placed on the ligand atoms during minimization. See:
-
-
-
-
21
-
-
9344236011
-
-
Q. Li D. T. Chu A. Claiborne C. S. Cooper C. M. Lee K. Raye K. B. Berst P. Donner W. Wang L. Hasvold A. Fung Z. Ma M. Tufano R. Flamm L. L. Shen J. Baranowski A. Nilius J. Alder J. Meulbroek K. Marsh D. Crowell Y. Hui L. Seif L. M. Melcher J. Plattner J. Med. Chem. 1996 39 3070
-
(1996)
J. Med. Chem.
, vol.39
, pp. 3070
-
-
Li, Q.1
Chu, D.T.2
Claiborne, A.3
Cooper, C.S.4
Lee, C.M.5
Raye, K.6
Berst, K.B.7
Donner, P.8
Wang, W.9
Hasvold, L.10
Fung, A.11
Ma, Z.12
Tufano, M.13
Flamm, R.14
Shen, L.L.15
Baranowski, J.16
Nilius, A.17
Alder, J.18
Meulbroek, J.19
Marsh, K.20
Crowell, D.21
Hui, Y.22
Seif, L.23
Melcher, L.M.24
Plattner, J.25
more..
|